166 related articles for article (PubMed ID: 24022213)
1. p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
Felisiak-Golabek A; Dansonka-Mieszkowska A; Rzepecka IK; Szafron L; Kwiatkowska E; Konopka B; Podgorska A; Rembiszewska A; Kupryjanczyk J
Cancer Biol Ther; 2013 Oct; 14(10):973-81. PubMed ID: 24022213
[TBL] [Abstract][Full Text] [Related]
2. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.
Kannan K; Coarfa C; Rajapakshe K; Hawkins SM; Matzuk MM; Milosavljevic A; Yen L
PLoS Genet; 2014 Mar; 10(3):e1004216. PubMed ID: 24675677
[TBL] [Abstract][Full Text] [Related]
3. Polypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells.
Lin S; Wang MJ; Tseng KY
PLoS One; 2013; 8(3):e58227. PubMed ID: 23536791
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
Salmena L; Shaw P; Fans I; McLaughlin ; Rosen B; Risch H; Mitchell C; Sun P; Narod SA; Kotsopoulos J
Eur J Gynaecol Oncol; 2015; 36(3):260-7. PubMed ID: 26189250
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
[TBL] [Abstract][Full Text] [Related]
6. TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.
Kupryjanczyk J; Kraszewska E; Ziolkowska-Seta I; Madry R; Timorek A; Markowska J; Stelmachow J; Bidzinski M;
BMC Cancer; 2008 Jan; 8():27. PubMed ID: 18230133
[TBL] [Abstract][Full Text] [Related]
7. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
8. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.
Felisiak-Golabek A; Rembiszewska A; Rzepecka IK; Szafron L; Madry R; Murawska M; Napiorkowski T; Sobiczewski P; Osuch B; Kupryjanczyk J;
J Ovarian Res; 2011 Nov; 4(1):20. PubMed ID: 22075440
[TBL] [Abstract][Full Text] [Related]
9. Embryonic Expression and Function of the
Doherty JR; Nilsson LM; Kuliyev E; Zhu H; Matthew R; Cleveland JL; Mead PE; Roussel MF
Cell Dev Biol; 2014 Feb; 3(1):. PubMed ID: 25309971
[TBL] [Abstract][Full Text] [Related]
10. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; ; DeFazio A; Kaufmann S; Churchman M; Gourley C; Stephens AN; Meagher NS; Ramus SJ; Antill YC; Campbell I; Scott CL; Köbel M; Gorringe KL;
Mod Pathol; 2021 Jan; 34(1):194-206. PubMed ID: 32724153
[TBL] [Abstract][Full Text] [Related]
11. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
[TBL] [Abstract][Full Text] [Related]
12. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
13. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis.
Buchold GM; Magyar PL; Arumugam R; Lee MM; O'Brien DA
Mol Reprod Dev; 2007 Aug; 74(8):997-1007. PubMed ID: 17342741
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
15. Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.
Han X; Zhang J; Peng Y; Peng M; Chen X; Chen H; Song J; Hu X; Ye M; Li J; Sankaran VG; Hillyer CD; Mohandas N; An X; Liu J
Blood; 2017 Jan; 129(2):226-237. PubMed ID: 27879259
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-induced unfolding regulates p19
Kumar A; Gopalswamy M; Wolf A; Brockwell DJ; Hatzfeld M; Balbach J
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3344-3349. PubMed ID: 29531090
[TBL] [Abstract][Full Text] [Related]
17. TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.
Ziółkowska-Seta I; Madry R; Kraszewska E; Szymańska T; Timorek A; Rembiszewska A; Kupryjańczyk J
Gynecol Oncol; 2009 Jan; 112(1):179-84. PubMed ID: 18937971
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.
Rzepecka IK; Szafron LM; Stys A; Felisiak-Golabek A; Podgorska A; Timorek A; Sobiczewski P; Pienkowska-Grela B; El-Bahrawy M; Kupryjanczyk J
Gynecol Oncol; 2017 Feb; 144(2):369-376. PubMed ID: 27939982
[TBL] [Abstract][Full Text] [Related]
19. P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1.
Gilles L; Guièze R; Bluteau D; Cordette-Lagarde V; Lacout C; Favier R; Larbret F; Debili N; Vainchenker W; Raslova H
Blood; 2008 Apr; 111(8):4081-91. PubMed ID: 18276842
[TBL] [Abstract][Full Text] [Related]
20. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging.
Hilpert M; Legrand C; Bluteau D; Balayn N; Betems A; Bluteau O; Villeval JL; Louache F; Gonin P; Debili N; Plo I; Vainchenker W; Gilles L; Raslova H
Stem Cell Reports; 2014 Dec; 3(6):1085-102. PubMed ID: 25458892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]